Welcome to SerendeX 

Serendex develops novel therapies for critical lung diseases. We are entirely focused on inhaled drug delivery because topical (local) therapy is usually much safer than systemic therapy. (Read more)

As a specialty biopharmaceutical drug development company we identify novel pulmonary uses for known drugs. We have filed for 10 new use patents for 8 already approved and marketed drugs for high-mortality patients with difficult-to-treat lung disease indications.  (Read more)

"Drug-Transformation" is the term we use to describe our drug development process – from idea, via IP rights to clinical development. (Read more)